06.10.23
Global Health
Researchers are using TBIJ's findings to create device that will screen for poor-quality medicines that are sold around the world
29.06.23
Poor-quality drug has been bought even when the gold-standard has been available – and sits on hospitals shelves today
27.06.23
‘The work of the Bureau was instrumental in bringing this scandal to the attention of the medical community,’ an expert said
25.01.23
Reporting by the Bureau reveals that at least a dozen brands of asparaginase, a key childhood cancer drug, have been proven to be poor quality, with ten still on the market.
10.11.22
How Big Pharma and various government officials worked to water down a radical proposal aimed at giving poorer countries greater access to vaccines
04.02.22
Our Impact
Unearthing facts, uncovering wrongdoing, collaboration and meaningful storytelling made the Bureau’s journalism more impactful than ever in 2021
25.05.21
Medical oxygen has become vital as Covid-19 spreads – and the gap in access to it is stark
19.04.21
Pharma giant had previously demanded governments put up state assets as collateral for Covid19 vaccine deals
10.03.21
An unredacted Pfizer contract with the Dominican Republic shows the company has been given wide-ranging immunity against legal action, meaning it cannot be held liable for problems at any step of its...
23.02.21
The Bureau has learned that the pharmaceutical giant also insists on indemnity against its own negligence in hardball negotiations with Latin American countries
